|
1
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yee GP, de Souza P and Khachigian LM:
Current and potential treatments for cervical cancer. Curr Cancer
Drug Targets. 13:205–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith RA, Brooks D, Cokkinides V, Saslow D
and Brawley OW: Cancer screening in the United States, 2013: A
review of current American Cancer Society guidelines, current
issues in cancer screening, and new guidance on cervical cancer
screening and lung cancer screening. CA Cancer J Clin. 63:88–105.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen LL and Yang L: Regulation of circRNA
biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen LL: The biogenesis and emerging roles
of circular RNAs. Nat Rev Mol Cell Biol. 17:205–211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan H, Li T, Jiang Y, Pan C, Ding Y, Huang
Z, Yu H and Kong D: Overexpression of circular RNA ciRS-7 abrogates
the tumor suppressive effect of miR-7 on gastric cancer via
PTEN/PI3K/AKT signaling pathway. J Cell Biochem. 119:440–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Glazar P, Papavasileiou P and Rajewsky N:
circBase: A database for circular RNAs. RNA. 20:1666–1670. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv D, Zhen Z and Huang D: MicroRNA-432 is
downregulated in osteosarcoma and inhibits cell proliferation and
invasion by directly targeting metastasis-associated in colon
cancer-1. Exp Ther Med. 17:919–926. 2019.PubMed/NCBI
|
|
19
|
Wu K, Ma L and Zhu J: miR4835p promotes
growth, invasion and selfrenewal of gastric cancer stem cells by
Wnt/betacatenin signaling. Mol Med Rep. 14:3421–3428. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu F, Cai Y, Rong X, Chen J, Zheng D,
Chen L, Zhang J, Luo R, Zhao P and Ruan J: MiR-661 promotes tumor
invasion and metastasis by directly inhibiting RB1 in non small
cell lung cancer. Mol Cancer. 16:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Li F and Zhu L: Clinical
significance and functions of microRNA-93/CDKN1A axis in human
cervical cancer. Life Sci. 209:242–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pedroza-Torres A, Campos-Parra AD,
Millan-Catalan O, Loissell-Baltazar YA, Zamudio-Meza H, Cantú de
León D, Montalvo-Esquivel G, Isla-Ortiz D, Herrera LA,
Ángeles-Zaragoza Ó, et al: MicroRNA-125 modulates radioresistance
through targeting p21 in cervical cancer. Oncol Rep. 39:1532–1540.
2018.PubMed/NCBI
|
|
23
|
Tan D, Zhou C, Han S, Hou X, Kang S and
Zhang Y: MicroRNA-378 enhances migration and invasion in cervical
cancer by directly targeting autophagy-related protein 12. Mol Med
Rep. 17:6319–6326. 2018.PubMed/NCBI
|
|
24
|
Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC,
Zhang T, Li Y and Wang GY: Downregulation of miR-432 activates
Wnt/β-catenin signaling and promotes human hepatocellular carcinoma
proliferation. Oncotarget. 6:7866–7879. 2015.PubMed/NCBI
|
|
25
|
Das E and Bhattacharyya NP: MicroRNA-432
contributes to dopamine cocktail and retinoic acid induced
differentiation of human neuroblastoma cells by targeting NESTIN
and RCOR1 genes. FEBS Lett. 588:1706–1714. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen L, Kong G, Zhang C, Dong H, Yang C,
Song G, Guo C, Wang L and Yu H: MicroRNA-432 functions as a tumor
suppressor gene through targeting E2F3 and AXL in lung
adenocarcinoma. Oncotarget. 7:20041–20053. 2016.PubMed/NCBI
|
|
27
|
Gollob JA, Wilhelm S, Carter C and Kelley
SL: Role of Raf kinase in cancer: Therapeutic potential of
targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol.
33:392–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Downward J: Targeting RAS signalling
pathways in cancer therapy. Nat Rev Cancer. 3:11–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leicht DT, Balan V, Kaplun A, Singh-Gupta
V, Kaplun L, Dobson M and Tzivion G: Raf kinases: Function,
regulation and role in human cancer. Biochim Biophys Acta.
1773:1196–1212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kersemaekers AM, Fleuren GJ, Kenter GG,
Van den Broek LJ, Uljee SM, Hermans J and Van de Vijver MJ:
Oncogene alterations in carcinomas of the uterine cervix:
Overexpression of the epidermal growth factor receptor is
associated with poor prognosis. Clin Cancer Res. 5:577–586.
1999.PubMed/NCBI
|
|
31
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao
L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, et al: The
landscape of circular RNA in cancer. Cell. 176:869–881.e13. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA biomarker, is involved in
hepatocellular crcinoma development. Medicine (Baltimore).
95:e38112016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen
L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66
promote colon cancer growth and metastasis. Cancer Res.
77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang PL, Liu B, Xia Y, Pan CF, Ma T and
Chen YJ: Long non-coding RNA-low expression in tumor inhibits the
invasion and metastasis of esophageal squamous cell carcinoma by
regulating p53 expression. Mol Med Rep. 13:3074–3082. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lasda E and Parker R: Circular RNAs:
Diversity of form and function. RNA. 20:1829–1842. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gullick WJ, Marsden JJ, Whittle N, Ward B,
Bobrow L and Waterfield MD: Expression of epidermal growth factor
receptors on human cervical, ovarian, and vulval carcinomas. Cancer
Res. 46:285–292. 1986.PubMed/NCBI
|
|
38
|
Biesterfeld S, Schuh S, Muys L, Rath W,
Mittermayer C and Schroder W: Absence of epidermal growth factor
receptor expression in squamous cell carcinoma of the uterine
cervix is an indicator of limited tumor disease. Oncol Rep.
6:205–209. 1999.PubMed/NCBI
|
|
39
|
Yoshioka K: Scaffold proteins in mammalian
MAP kinase cascades. J Biochem. 135:657–661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kohno M and Pouyssegur J: Targeting the
ERK signaling pathway in cancer therapy. Ann Med. 38:200–211. 2006.
View Article : Google Scholar : PubMed/NCBI
|
